Status:
COMPLETED
Development of Imaging, Clinical and Biochemical Bio-Markers for Parkinson's Disease
Lead Sponsor:
Institute for Neurodegenerative Disorders
Collaborating Sponsors:
United States Department of Defense
Molecular NeuroImaging
Conditions:
Parkinson's Disease
Parkinsonian Syndrome
Eligibility:
All Genders
22+ years
Phase:
PHASE2
Brief Summary
We propose to build on preliminary data evaluating non-dopaminergic/non-motor clinical biomarkers to more fully assess these markers at the threshold of Parkinson disease (PD). Development of reliabl...
Detailed Description
Two hundred patients who have undergone neurological evaluation by their general community neurologist and have a questionable diagnosis of PD will be recruited to participate in this study. Subjects ...
Eligibility Criteria
Inclusion
- Older than 21
- Any parkinsonian symptoms
- Referral by community neurologist
- Parkinsonian symptoms for less than 2 years duration.
- Willingness to follow the study plan.
Exclusion
- Pregnancy
- Significant medical disease including abnormalities on screening biochemical or hematological labs or abnormal electrocardiogram (ECG - tracing of the electrical activity of the heart)
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2010
Estimated Enrollment :
225 Patients enrolled
Trial Details
Trial ID
NCT00315250
Start Date
January 1 2006
End Date
June 1 2010
Last Update
May 9 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute for Neurodegenerative Disorders
New Haven, Connecticut, United States, 06510